Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group

Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2022-04, Vol.12, p.805613-805613
Main Authors: Zannoni, Gian Franco, Bragantini, Emma, Castiglione, Francesca, Fassan, Matteo, Troncone, Giancarlo, Inzani, Frediano, Pesci, Anna, Santoro, Angela, Fraggetta, Filippo
Format: Article
Language:English
Subjects:
endometrial cancer
histomolecular classification
Oncology
pathological guidelines
prognostic markers
prognostic stratification
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163
cites cdi_FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163
container_end_page 805613
container_issue
container_start_page 805613
container_title Frontiers in oncology
container_volume 12
creator Zannoni, Gian Franco
Bragantini, Emma
Castiglione, Francesca
Fassan, Matteo
Troncone, Giancarlo
Inzani, Frediano
Pesci, Anna
Santoro, Angela
Fraggetta, Filippo
description Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications of the proposed new histomolecular classification system for ECs. In view of the substantial genetic and morphological heterogeneity in ECs, both classical pthological parameters and molecular classifiers have to be integrated in the pathology report. This review will focus on the most commonly adopted immunohistochemical and molecular biomarkers in daily clinical characterization of EC, referring to the most recent published recommendations, guidelines, and expert opinions.
doi_str_mv 10.3389/fonc.2022.805613
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5e276f51ce8c481f86a789794755ea0c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_5e276f51ce8c481f86a789794755ea0c</doaj_id><sourcerecordid>2655101491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163</originalsourceid><addsrcrecordid>eNpVkk1vEzEQhlcIRKvSOyfkI5ek_s6aAxKsSolUiYoPiZs18Y5Tl1072LuV-iv4yzikVK0v9oznfcZjvU3zmtGlEK058ym6JaecL1uqNBPPmmPOhVwYKX4-f3Q-ak5LuaF1aUUZFS-bI6GkFtyY4-ZPN-eMcSJXOW1jKlNwBGJfQ-yDm8Itko8hjZB_YS7Ep0zOY59GnHKAgXQQHWYSIumGEIOrqasMVebwHfmKLo0jxh6mkGI5qx12qdQSn9NIpmsk6wmGAJF8m-b-jlzkNO9eNS88DAVP7_eT5sen8-_d58Xll4t19-Fy4YTh08IoutEATmwkSOollbSlWm6MAY4Cet4rlNwoJjx3K2G09JRx4F4pUJ5pcdKsD9w-wY3d5VBHvLMJgv2XSHlrIdc5BrQK-Up7xRy2TrbMtxpWrVkZuVIKgbrKen9g7ebNiL2r35lheAJ9ehPDtd2mW2sol0LSCnh7D8jp94xlsmMoDocBIqa5WK6VYpRJw2opPZS6nErJ6B_aMGr3trB7W9i9LezBFlXy5vHzHgT_TSD-AjOctmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655101491</pqid></control><display><type>article</type><title>Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group</title><source>PubMed Central</source><creator>Zannoni, Gian Franco ; Bragantini, Emma ; Castiglione, Francesca ; Fassan, Matteo ; Troncone, Giancarlo ; Inzani, Frediano ; Pesci, Anna ; Santoro, Angela ; Fraggetta, Filippo</creator><creatorcontrib>Zannoni, Gian Franco ; Bragantini, Emma ; Castiglione, Francesca ; Fassan, Matteo ; Troncone, Giancarlo ; Inzani, Frediano ; Pesci, Anna ; Santoro, Angela ; Fraggetta, Filippo</creatorcontrib><description>Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications of the proposed new histomolecular classification system for ECs. In view of the substantial genetic and morphological heterogeneity in ECs, both classical pthological parameters and molecular classifiers have to be integrated in the pathology report. This review will focus on the most commonly adopted immunohistochemical and molecular biomarkers in daily clinical characterization of EC, referring to the most recent published recommendations, guidelines, and expert opinions.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2022.805613</identifier><identifier>PMID: 35463299</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>endometrial cancer ; histomolecular classification ; Oncology ; pathological guidelines ; prognostic markers ; prognostic stratification</subject><ispartof>Frontiers in oncology, 2022-04, Vol.12, p.805613-805613</ispartof><rights>Copyright © 2022 Zannoni, Bragantini, Castiglione, Fassan, Troncone, Inzani, Pesci, Santoro and Fraggetta.</rights><rights>Copyright © 2022 Zannoni, Bragantini, Castiglione, Fassan, Troncone, Inzani, Pesci, Santoro and Fraggetta 2022 Zannoni, Bragantini, Castiglione, Fassan, Troncone, Inzani, Pesci, Santoro and Fraggetta</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163</citedby><cites>FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024340/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024340/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35463299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zannoni, Gian Franco</creatorcontrib><creatorcontrib>Bragantini, Emma</creatorcontrib><creatorcontrib>Castiglione, Francesca</creatorcontrib><creatorcontrib>Fassan, Matteo</creatorcontrib><creatorcontrib>Troncone, Giancarlo</creatorcontrib><creatorcontrib>Inzani, Frediano</creatorcontrib><creatorcontrib>Pesci, Anna</creatorcontrib><creatorcontrib>Santoro, Angela</creatorcontrib><creatorcontrib>Fraggetta, Filippo</creatorcontrib><title>Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group</title><title>Frontiers in oncology</title><addtitle>Front Oncol</addtitle><description>Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications of the proposed new histomolecular classification system for ECs. In view of the substantial genetic and morphological heterogeneity in ECs, both classical pthological parameters and molecular classifiers have to be integrated in the pathology report. This review will focus on the most commonly adopted immunohistochemical and molecular biomarkers in daily clinical characterization of EC, referring to the most recent published recommendations, guidelines, and expert opinions.</description><subject>endometrial cancer</subject><subject>histomolecular classification</subject><subject>Oncology</subject><subject>pathological guidelines</subject><subject>prognostic markers</subject><subject>prognostic stratification</subject><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkk1vEzEQhlcIRKvSOyfkI5ek_s6aAxKsSolUiYoPiZs18Y5Tl1072LuV-iv4yzikVK0v9oznfcZjvU3zmtGlEK058ym6JaecL1uqNBPPmmPOhVwYKX4-f3Q-ak5LuaF1aUUZFS-bI6GkFtyY4-ZPN-eMcSJXOW1jKlNwBGJfQ-yDm8Itko8hjZB_YS7Ep0zOY59GnHKAgXQQHWYSIumGEIOrqasMVebwHfmKLo0jxh6mkGI5qx12qdQSn9NIpmsk6wmGAJF8m-b-jlzkNO9eNS88DAVP7_eT5sen8-_d58Xll4t19-Fy4YTh08IoutEATmwkSOollbSlWm6MAY4Cet4rlNwoJjx3K2G09JRx4F4pUJ5pcdKsD9w-wY3d5VBHvLMJgv2XSHlrIdc5BrQK-Up7xRy2TrbMtxpWrVkZuVIKgbrKen9g7ebNiL2r35lheAJ9ehPDtd2mW2sol0LSCnh7D8jp94xlsmMoDocBIqa5WK6VYpRJw2opPZS6nErJ6B_aMGr3trB7W9i9LezBFlXy5vHzHgT_TSD-AjOctmw</recordid><startdate>20220408</startdate><enddate>20220408</enddate><creator>Zannoni, Gian Franco</creator><creator>Bragantini, Emma</creator><creator>Castiglione, Francesca</creator><creator>Fassan, Matteo</creator><creator>Troncone, Giancarlo</creator><creator>Inzani, Frediano</creator><creator>Pesci, Anna</creator><creator>Santoro, Angela</creator><creator>Fraggetta, Filippo</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220408</creationdate><title>Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group</title><author>Zannoni, Gian Franco ; Bragantini, Emma ; Castiglione, Francesca ; Fassan, Matteo ; Troncone, Giancarlo ; Inzani, Frediano ; Pesci, Anna ; Santoro, Angela ; Fraggetta, Filippo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>endometrial cancer</topic><topic>histomolecular classification</topic><topic>Oncology</topic><topic>pathological guidelines</topic><topic>prognostic markers</topic><topic>prognostic stratification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zannoni, Gian Franco</creatorcontrib><creatorcontrib>Bragantini, Emma</creatorcontrib><creatorcontrib>Castiglione, Francesca</creatorcontrib><creatorcontrib>Fassan, Matteo</creatorcontrib><creatorcontrib>Troncone, Giancarlo</creatorcontrib><creatorcontrib>Inzani, Frediano</creatorcontrib><creatorcontrib>Pesci, Anna</creatorcontrib><creatorcontrib>Santoro, Angela</creatorcontrib><creatorcontrib>Fraggetta, Filippo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zannoni, Gian Franco</au><au>Bragantini, Emma</au><au>Castiglione, Francesca</au><au>Fassan, Matteo</au><au>Troncone, Giancarlo</au><au>Inzani, Frediano</au><au>Pesci, Anna</au><au>Santoro, Angela</au><au>Fraggetta, Filippo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group</atitle><jtitle>Frontiers in oncology</jtitle><addtitle>Front Oncol</addtitle><date>2022-04-08</date><risdate>2022</risdate><volume>12</volume><spage>805613</spage><epage>805613</epage><pages>805613-805613</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications of the proposed new histomolecular classification system for ECs. In view of the substantial genetic and morphological heterogeneity in ECs, both classical pthological parameters and molecular classifiers have to be integrated in the pathology report. This review will focus on the most commonly adopted immunohistochemical and molecular biomarkers in daily clinical characterization of EC, referring to the most recent published recommendations, guidelines, and expert opinions.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35463299</pmid><doi>10.3389/fonc.2022.805613</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-943X
ispartof Frontiers in oncology, 2022-04, Vol.12, p.805613-805613
issn 2234-943X
2234-943X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5e276f51ce8c481f86a789794755ea0c
source PubMed Central
subjects endometrial cancer
histomolecular classification
Oncology
pathological guidelines
prognostic markers
prognostic stratification
title Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A43%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Prognostic%20and%20Predictive%20Biomarkers%20for%20Endometrial%20Cancer%20in%20Clinical%20Practice:%20Recommendations/Proposal%20from%20the%20Italian%20Study%20Group&rft.jtitle=Frontiers%20in%20oncology&rft.au=Zannoni,%20Gian%20Franco&rft.date=2022-04-08&rft.volume=12&rft.spage=805613&rft.epage=805613&rft.pages=805613-805613&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2022.805613&rft_dat=%3Cproquest_doaj_%3E2655101491%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-950b6aac3b4a40f40408064b99a2e3ad2d5e429513f2c73964f012a2f55a5f163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2655101491&rft_id=info:pmid/35463299&rfr_iscdi=true